Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Ligon

Showing results (91-100 of 324) with videos related to

Pageof 33
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and TemozolomideRifaquat Rahman, Lorenzo Trippa, Stephanie Alden, et al.
Journal of Visualized Experiments : Jove|November 18, 2015
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug TherapiesEmily J Chadwick, David P Yang, Mariella G Filbin, et al.
Cancer Discovery|August 14, 2021
Rates and Patterns of Clonal Oncogenic Mutations in the Normal Human BrainJavier Ganz, Eduardo A Maury, Basheer Becerra, et al.
Cancer Cell|March 15, 2011
The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant gliomaShwetal Mehta, Emmanuelle Huillard, Santosh Kesari, et al.
Science (New York, N.Y.)|September 18, 2007
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapiesJayne M Stommel, Alec C Kimmelman, Haoqiang Ying, et al.
World Neurosurgery|July 31, 2015
Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate DifferentiationYun Jee Kang, Wenya Linda Bi, Adrian M Dubuc, et al.
Neuro-Oncology Advances|March 17, 2023
Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatmentJessica W Tsai, Jungwhan John Choi, Hakim Ouaalam, et al.
Plos One|April 12, 2011
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implicationsDora Dias-Santagata, Quynh Lam, Kathy Vernovsky, et al.
NPJ Precision Oncology|June 19, 2026
Clinical responses to trastuzumab deruxtecan in molecularly defined ependymomaL Nicolas Gonzalez Castro, Yi-Chien Wu, Jia-Ren Lin, et al.
Cancer Research|August 17, 2019
Tie2-FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in GlioblastomaXiaolong Li, Emmanuel Martinez-Ledesma, Chen Zhang, et al.
Pageof 33

Showing results (91-100 of 324) with videos related to

Sort By:
Pageof 33
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and TemozolomideRifaquat Rahman, Lorenzo Trippa, Stephanie Alden, et al.
Journal of Visualized Experiments : Jove|November 18, 2015
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug TherapiesEmily J Chadwick, David P Yang, Mariella G Filbin, et al.
Cancer Discovery|August 14, 2021
Rates and Patterns of Clonal Oncogenic Mutations in the Normal Human BrainJavier Ganz, Eduardo A Maury, Basheer Becerra, et al.
Cancer Cell|March 15, 2011
The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant gliomaShwetal Mehta, Emmanuelle Huillard, Santosh Kesari, et al.
Science (New York, N.Y.)|September 18, 2007
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapiesJayne M Stommel, Alec C Kimmelman, Haoqiang Ying, et al.
World Neurosurgery|July 31, 2015
Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate DifferentiationYun Jee Kang, Wenya Linda Bi, Adrian M Dubuc, et al.
Neuro-Oncology Advances|March 17, 2023
Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatmentJessica W Tsai, Jungwhan John Choi, Hakim Ouaalam, et al.
Plos One|April 12, 2011
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implicationsDora Dias-Santagata, Quynh Lam, Kathy Vernovsky, et al.
NPJ Precision Oncology|June 19, 2026
Clinical responses to trastuzumab deruxtecan in molecularly defined ependymomaL Nicolas Gonzalez Castro, Yi-Chien Wu, Jia-Ren Lin, et al.
Cancer Research|August 17, 2019
Tie2-FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in GlioblastomaXiaolong Li, Emmanuel Martinez-Ledesma, Chen Zhang, et al.
Pageof 33